This study is looking at how well valbenazine works for adults who have tardive dyskinesia (TD). TD is a movement disorder that can cause involuntary, repetitive movements. You might be eligible if you have TD and are currently taking, or have recently stopped taking, another medication called a VMAT2 inhibitor. To join, you need to be at least 18 years old and have a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder. The main goal is to see if valbenazine can reduce your involuntary movements, as measured by a special scale (AIMS) after 24 weeks. The current status of this study is unclear, and it plans to enroll 50 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 50 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome is measured at Week 24, suggesting follow-up for at least this duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.